Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.71B |
| 2 |
Microsoft
MSFT
|
+$3.52B |
| 3 |
Amazon
AMZN
|
+$2.04B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.87B |
| 5 |
Eli Lilly
LLY
|
+$1.31B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.8B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.78B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$703M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$611M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.3% |
| 2 | Healthcare | 12.11% |
| 3 | Financials | 10.63% |
| 4 | Consumer Discretionary | 8.09% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Evolus
EOLS
$501M
| $448K | ﹤0.01% |
59,625
-3,375
| -5% | -$26.1K |
|
5127
Omeros
OMER
$959M
| $447K | ﹤0.01% |
197,877
-172,547
| -47% | -$476K |
|
5128
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $447K | ﹤0.01% |
1,979
-18,336
| -90% | -$5.02M |
|
5129
ProShares Ultra Silver
AGQ
$1.38B
| $446K | ﹤0.01% |
13,927
-13,766
| -50% | -$354K |
|
5130
Harrow
HROW
$1.51B
| $445K | ﹤0.01% |
30,161
+18,365
| +156% | +$220K |
|
5131
Pangaea Logistics
PANL
$485M
| $441K | ﹤0.01% |
85,674
+11,417
| +15% | +$56.4K |
|
5132
iShares US & Intl High Yield Corp Bond ETF
GHYG
$199M
| $441K | ﹤0.01% |
10,652
-8,917
| -46% | -$362K |
|
5133
Annexon
ANNX
$886M
| $439K | ﹤0.01% |
84,971
+30,026
| +55% | +$165K |
|
5134
Invesco CurrencyShares Canadian Dollar Trust
FXC
$73.6M
| $436K | ﹤0.01% |
6,038
-3,962
| -40% | -$285K |
|
5135
UroGen Pharma
URGN
$2.29B
| $436K | ﹤0.01% |
49,149
+4,139
| +9% | +$39.2K |
|
5136
Fennec Pharmaceuticals
FENC
$402M
| $436K | ﹤0.01% |
45,376
+9,314
| +26% | +$82.4K |
|
5137
Nexa Resources
NEXA
$1.87B
| $435K | ﹤0.01% |
72,184
-65,456
| -48% | -$355K |
|
5138
Village Farms International
VFF
$253M
| $435K | ﹤0.01% |
324,495
-50,298
| -13% | -$95.7K |
|
5139
Praxis Precision Medicines
PRAX
$10.1B
| $433K | ﹤0.01% |
12,137
-6,188
| -34% | -$193K |
|
5140
Princeton Bancorp
BPRN
$287M
| $432K | ﹤0.01% |
13,634
+3,995
| +41% | +$125K |
|
|
MYND
5141
Mynd.ai
MYND
$19.3M
| $432K | ﹤0.01% |
76,220
-38
| -0% | -$286 |
|
5142
Direxion Daily FTSE China Bull 3X ETF
YINN
$731M
| $431K | ﹤0.01% |
9,337
+4,924
| +112% | +$185K |
|
5143
Actinium Pharmaceuticals
ATNM
$25M
| $431K | ﹤0.01% |
40,473
-9,699
| -19% | -$98.4K |
|
5144
Pharvaris
PHVS
$2.44B
| $430K | ﹤0.01% |
38,180
+19,085
| +100% | +$100K |
|
5145
Alta Equipment Group
ALTG
$245M
| $429K | ﹤0.01% |
32,539
+11,378
| +54% | +$137K |
|
5146
Vanguard Ultra-Short Bond ETF
VUSB
$9.33B
| $428K | ﹤0.01% |
8,730
+2,170
| +33% | +$106K |
|
|
EXAI
5147
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $426K | ﹤0.01% |
79,963
+46,087
| +136% | +$291K |
|
|
TIG
5148
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $426K | ﹤0.01% |
70,966
-62,072
| -47% | -$216K |
|
5149
Design Therapeutics
DSGN
$876M
| $425K | ﹤0.01% |
41,424
-17,511
| -30% | -$237K |
|
5150
Kewaunee Scientific
KEQU
$106M
| $423K | ﹤0.01% |
27,291
+111
| +0.4% | +$1.87K |
|
Similar funds
Morgan Stanley's Q4 2022 Portfolio in Review
As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.
- Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
- Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
- Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
- Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
- Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
- Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
- Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.
Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.